The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ursodiol for Primary Sclerosing Cholangitis
Lindor, K. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361003 · Cited by 598
Self-citationClinicopathologic features of the syndrome of primary sclerosing cholangitis
Wiesner, R. H., & LaRusso, N. F. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90131-6 · Cited by 550
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
Broomé, U., Löfberg, R., Veress, B., & Eriksson, L. S. (1995) · Hepatology · doi:10.1002/hep.1840220511 · Cited by 481
Tung, B. Y., Emond, M. J., Haggitt, R. C., Bronner, M. P., Kimmey, M. B., Kowdley, K. V., & Brentnall, T. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00008 · Cited by 469
Reddy, B. S., & Wynder, E. L. (1977) · Cancer · doi:10.1002/1097-0142(197706)39:6<2533::aid-cncr2820390634>3.0.co;2-x · Cited by 410
Rubin, P. H., Friedman, S., Harpaz, N., Goldstein, E., Weiser, J., Schiller, J., Waye, J. D., & Present, D. H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70279-9 · Cited by 355
Brentnall, T., Haggitt, R., Rabinovitch, P., Kimmey, M., Bronner, M., Levine, D., Kowdley, K., Stevens, A., Crispin, D., Emond, M., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566577 · Cited by 337
Marchesa, P., Lashner, B. A., Lavery, I. C., Milsom, J. W., Hull, T. L., Strong, S. A., Church, J. M., Navarro, G., & Fazio, V. W. (1997) · PubMed · Cited by 329
Engelsgjerd, M., Farraye, F. A., & Odze, R. D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70278-7 · Cited by 300
Kornfeld, D., Ekbom, A., & Ihre, T. (1997) · Gut · doi:10.1136/gut.41.4.522 · Cited by 251
The Risk for Cancer Or Dysplasia in Ulcerative Colitis Patients With Primary Sclerosing Cholangitis
Shetty, K., Rybicki, L. A., Brzezinski, A., Carey, W. D., & Lashner, B. A. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00212-9 · Cited by 245
Increased serum deoxycholic acid levels in men with colorectal adenomas
Bayerdörffer, E., Mannes, G. A., Richter, W. O., Ochsenkühn, T., Wiebecke, B., Köpcke, W., & Paumgartner, G. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90846-5 · Cited by 234
Dl, E., Holubec, H., Wali, R. K., Jolley, C. S., BISSONNETTE, M., Bhattacharyya, A. K., Roy, H. K., Khare, S., & Brasitus, T. A. (1994) · PubMed · Cited by 209
Martinez, J. D., Stratagoules, E. D., LaRue, J. M., Powell, A. A., Gause, P. R., Craven, M. T., Payne, C. M., Powell, M. B., Gerner, E. W., & Earnest, D. L. (1998) · Nutrition and Cancer · doi:10.1080/01635589809514689 · Cited by 205
Broomé, U., Lindberg, G., & Löfberg, R. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90308-l · Cited by 191
Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal, P., & Sonnenberg, A. (1996) · PubMed · Cited by 171
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential*1
Broomé, U. (1995) · Hepatology · doi:10.1016/0270-9139(95)90144-2 · Cited by 150
Colonic mucosal proliferation is related to serum deoxycholic acid levels
Ochsenkühn, T., Bayerdörffer, E., Meining, A. G., Schinkel, M., Thiede, C., Nüssler, V., Sackmann, M. F., Hatz, R. A., Neubauer, A., & Paumgartner, G. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990415)85:8<1664::aid-cncr4>3.3.co;2-f · Cited by 140
Risk of colorectal neoplasia in patients with primary sclerosing cholangitis
Loftus, E. V., Sandborn, W., Tremaine, W., Mahoney, D., Zinsmeister, A., Offord, K., & Melton, L. J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566590 · Cited by 136
Self-citationCANCER RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Lewis, J. D., Deren, J. J., & Lichtenstein, G. R. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70065-0 · Cited by 132
Stadler, J., Yeung, K. S., Furrer, R., Marcon, N. E., Himal, H. S., & Bruce, W. R. (1988) · Cancer Letters · doi:10.1016/0304-3835(88)90023-7 · Cited by 126
D’Haens, G., Lashner, B. A., & Hanauer, S. B. (1993) · PubMed · Cited by 113
Nuako, K. W., Ahlquist, D. A., Sandborn, W. J., Mahoney, D. W., Siems, D. M., & Zinsmeister, A. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980301)82:5<822::aid-cncr4>3.0.co;2-l · Cited by 99
Wali, R. K., Frawley, B. P., Hartmann, S., Roy, H. K., Khare, S., Scaglione-Sewell, B., Earnest, D. L., Sitrin, M. D., Brasitus, T. A., & Bissonnette, M. (1995) · PubMed · Cited by 89
FAECAL BILE ACIDS, DYSPLASIA, AND CARCINOMA IN ULCERATIVE COLITIS
Lewin, M. R., Clark, C. G., Hill, M. J., Lennard‐Jones, J. E., & Melville, D. M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91459-0 · Cited by 86
FAECAL BILE ACIDS, DYSPLASIA, AND CARCINOMA IN ULCERATIVE COLITIS
Hill, M. J., Lennard‐Jones, J. E., Melville, D. M., Neale, K. F., & Ritchie, J. K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90766-5 · Cited by 76
Ikegami, T., Matsuzaki, Y., Shoda, J., Kano, M., Hirabayashi, N., & Tanaka, N. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00248-1 · Cited by 69
Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis
Gürbüz, A. K., Giardiello, F. M., & Bayless, T. M. (1995) · Diseases of the Colon & Rectum · doi:10.1007/bf02053855 · Cited by 66
BATTA, A. K., Salen, G., Holubec, H., Brasitus, T. A., Alberts, D. S., & Earnest, D. L. (1998) · PubMed · Cited by 61
The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation
Rodrigues, C. M. P., Kren, B. T., Steer, C. J., & Setchell, K. D. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90750-5 · Cited by 60
Leidenius, M., Färkkilä, M. A., Kärkkäinen, P., Taskinen, E., Kellokumpu, I., & Höckerstedt, K. A. V. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529708996522 · Cited by 59
Risk factors of colorectal cancer in inflammatory bowel disease
Ricketts, R. R. (1997) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(97)90054-3 · Cited by 57
Rigas, B., Tsioulias, G. J., Allan, C. H., Wali, R. K., & Brasitus, T. A. (1994) · PubMed Central · Cited by 46
Prevention of N‐Methylnitrosourea‐induced Colon Tumorigenesis by Ursodeoxycholic Acid in F344 Rats
Narisawa, T., Fukaura, Y., Terada, K., & Sekiguchi, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00489.x · Cited by 46
The MAP kinase‐activated protein kinase 2 contains a proline‐rich SH3‐binding domain
Engel, K., Plath, K., & Gaestel, M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81628-d · Cited by 43
Narisawa, T., Fukaura, Y., Terada, K., & Sekiguchi, H. (1999) · PubMed · Cited by 32
Roy, H. K., Bissonnette, M., Frawley, B. P., Wali, R. K., Niedziela, S. M., Earnest, D., & Brasitus, T. A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00515-b · Cited by 31
Ricketts, R. R. (1998) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(98)90240-8 · Cited by 26
Cited by
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Metadata
- Authors
- Pardi, D. S., Loftus, E. V., Kremers, W. K., Keach, J., & Lindor, K. D.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 124
- Issue
- 4
- Pages
- 889-893
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2142578122
- Cited by
- 562
- References
- 38
- FWCI
- 17.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.